Gregor Bedenikovic
About Gregor Bedenikovic
Gregor Bedenikovic is the Hcp Events and Meetings Center of Expertise Lead for Switzerland and Austria at Bristol-Myers Squibb, based in New Jersey, United States.
Current Position at Bristol-Myers Squibb
Gregor Bedenikovic is the Hcp Events and Meetings Center of Expertise Lead for Switzerland and Austria at Bristol-Myers Squibb in New Jersey, United States. In his current role, which began on September 1, 2018, he leads a team of 10 direct reports in the pharmaceutical meeting and events departments. He manages all events involving healthcare professionals and organizations, advises local commercial and medical teams, and oversees contracting, payment handling, TOV reporting, and compliance checks.
Previous Roles at Bristol-Myers Squibb
Gregor Bedenikovic has held several positions at Bristol-Myers Squibb. From 2015 to 2018, he served as the Product Manager for Immunoscience. Before that, in 2015, he was the Product Manager for Pain and Virology for 5 months. Additionally, he worked as a Consultant and Junior Product Manager for Pain in 2014 for 7 months. His cumulative experience at Bristol-Myers Squibb has equipped him with comprehensive knowledge in various pharmaceutical product domains and event management.
Prior Experience and Internships
Before his tenure at Bristol-Myers Squibb, Gregor Bedenikovic worked at Telejob as an Event Organizer and in Marketing from 2012 to 2014 in Zurich, Switzerland. He also served as a Research Assistant at ETH Zurich from 2009 to 2014. Earlier, he interned at Fraunhofer USA Center for Molecular Biotechnology from 2007 to 2008 in Newark, Delaware, and at the 'Development of Industrial Products' Division at Sandoz in 2006 in Holzkirchen, Bavaria, Germany. These roles provided him with a solid foundation in event management, research, and product development.
Educational Background
Gregor Bedenikovic completed his education at several prestigious institutions. He earned a Master of Science in Molecular Biology from Leopold-Franzens Universität Innsbruck, where he also obtained a Bachelor of Science in Biology. Later, he pursued studies in Immunology at ETH Zurich from 2009 to 2013. His academic background has significantly contributed to his expertise in the fields of biology, molecular biology, and immunology.